Sklar J
Department of Pathology, Stanford University, California.
Am J Surg Pathol. 1990;14 Suppl 1:16-25.
Studies of DNA rearrangements in antigen receptor genes and at sites of chromosomal translocations are having an increasing impact on the diagnostic evaluation of lymphoid tissue biopsy specimens. Such rearrangements represent clonal molecular markers that can be very easily detected by Southern blot hybridization or polymerase chain reaction amplification. Detection of these markers can be useful in the diagnosis or subclassification of lymphoid neoplasms, particularly when morphologic or immunophenotypic findings alone are ambiguous. At the same time, application of DNA rearrangement to the evaluation of tissue specimens also has certain shortcomings and limitations, some of which may be overcome by current research methods or advances expected in the near future.
对抗原受体基因及染色体易位位点处DNA重排的研究,对淋巴组织活检标本的诊断评估影响日益增大。此类重排代表克隆性分子标志物,可通过Southern印迹杂交或聚合酶链反应扩增很容易地检测到。这些标志物的检测在淋巴肿瘤的诊断或亚型分类中可能有用,尤其是当单独的形态学或免疫表型结果不明确时。同时,将DNA重排应用于组织标本评估也有一定的缺点和局限性,其中一些可能会被当前的研究方法或不久的将来预期的进展所克服。